These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12776464)

  • 1. Healing prayer outcomes studies: consensus recommendations.
    Dusek JA; Astin JA; Hibberd PL; Krucoff MW
    Altern Ther Health Med; 2003; 9(3 Suppl):A44-53. PubMed ID: 12776464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ethics of randomization].
    Arpaillange P; Dion S
    Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599
    [No Abstract]   [Full Text] [Related]  

  • 3. [Randomization and comparison of final quality in clinical studies].
    Altman DG; Doré CJ
    Z Arztl Fortbild Qualitatssich; 2005; 99(10):629-34. PubMed ID: 16433266
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethical challenges to cell-based interventions for the central nervous system: some recommendations for clinical trials and practice.
    Schwartz PH; Kalichman MW
    Am J Bioeth; 2009 May; 9(5):41-3. PubMed ID: 19396684
    [No Abstract]   [Full Text] [Related]  

  • 5. Advantages and drawbacks of the Zelen design for randomized clinical trials.
    Horwitz RI; Feinstein AR
    J Clin Pharmacol; 1980 Jul; 20(7):425-7. PubMed ID: 7430410
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized clinical trials and research strategy.
    Simon R
    Cancer Treat Rep; 1982 May; 66(5):1083-7. PubMed ID: 7083212
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controlled clinical therapy studies].
    Michaelis J
    Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1947-50. PubMed ID: 7173057
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomization and efficiency in Zelen's single-consent design.
    Matts J; McHugh R
    Biometrics; 1987 Dec; 43(4):885-94. PubMed ID: 3427173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling the independent variables in the clinical study of prayer: the devil is in the details.
    Burks EJ
    Am Heart J; 2006 Oct; 152(4):e41-2. PubMed ID: 16996819
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethical considerations in clinical research.
    Jamrozik K
    P N G Med J; 1984 Mar; 27(1):4-6. PubMed ID: 6595904
    [No Abstract]   [Full Text] [Related]  

  • 11. The ethics of long-distance intercessory prayer.
    DeLashmutt M; Silva MC
    Nursingconnections; 2000; 13(3):40-3. PubMed ID: 12017923
    [No Abstract]   [Full Text] [Related]  

  • 12. Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Pepe--defending the rights of all individuals to have access to potential life-saving therapies and resuscitation studies.
    Pepe PE
    Acad Emerg Med; 2007 Apr; 14(4):e51-6. PubMed ID: 17341677
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of retroactive intercessory prayer. All randomised controlled trials require informed consent.
    Price CI
    BMJ; 2002 Apr; 324(7344):1037; author reply 1038-9. PubMed ID: 11977262
    [No Abstract]   [Full Text] [Related]  

  • 14. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercessory prayer and its effect on patients with rheumatoid arthritis.
    Williams T
    Ky Nurse; 2002; 50(1):16. PubMed ID: 11859558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding clinical trial outcomes: design, analysis, and interpretation.
    Jacobe HT; Leitenberger JJ; Bergstresser PR
    Dermatol Ther; 2007; 20(2):77-85. PubMed ID: 17537135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
    Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
    Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caregivers as subjects of clinical drug trials: a review of human subjects protection practices in published studies of Alzheimer's disease pharmacotherapies.
    Lingler JH; Parker LS; DeKosky ST; Schulz R
    IRB; 2006; 28(3):11-8. PubMed ID: 17036439
    [No Abstract]   [Full Text] [Related]  

  • 19. A new design for randomized trials.
    Rutstein DD
    N Engl J Med; 1979 Oct; 301(14):786. PubMed ID: 556240
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials in status epilepticus-The clinical perspective.
    Kälviäinen R
    Epilepsia; 2009 Dec; 50 Suppl 12():75-6. PubMed ID: 19941534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.